The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISA 2024 | The importance of collaboration between multidisciplinary teams when treating amyloidosis
Chafic Karam, MD, University of Pennsylvania, Philadelphia, PA, emphasizes the importance of collaboration between multidisciplinary teams when treating patients with amyloidosis. Amyloidosis is a multisystemic disease affecting various organs, necessitating coordinated care from specialists such as cardiologists, hematologists, nephrologists, and surgeons. This interview took place at the XIX International Symposium on Amyloidosis (ISA) in Rochester, MN.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
